JPS62239990A - Novel lipase and production thereof - Google Patents
Novel lipase and production thereofInfo
- Publication number
- JPS62239990A JPS62239990A JP8299186A JP8299186A JPS62239990A JP S62239990 A JPS62239990 A JP S62239990A JP 8299186 A JP8299186 A JP 8299186A JP 8299186 A JP8299186 A JP 8299186A JP S62239990 A JPS62239990 A JP S62239990A
- Authority
- JP
- Japan
- Prior art keywords
- lipase
- activity
- glycerol
- surfactant
- triglycerides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004882 Lipase Human genes 0.000 title claims abstract description 90
- 108090001060 Lipase Proteins 0.000 title claims abstract description 90
- 239000004367 Lipase Substances 0.000 title claims abstract description 89
- 235000019421 lipase Nutrition 0.000 title claims abstract description 89
- 238000004519 manufacturing process Methods 0.000 title claims description 18
- 230000000694 effects Effects 0.000 claims abstract description 43
- 239000004094 surface-active agent Substances 0.000 claims abstract description 28
- 241000228143 Penicillium Species 0.000 claims abstract description 9
- 241001507683 Penicillium aurantiogriseum Species 0.000 claims abstract description 8
- 150000003626 triacylglycerols Chemical class 0.000 claims description 19
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims 2
- 150000005215 alkyl ethers Chemical class 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 51
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 12
- 239000000194 fatty acid Substances 0.000 abstract description 12
- 229930195729 fatty acid Natural products 0.000 abstract description 12
- 210000002966 serum Anatomy 0.000 abstract description 12
- 150000004665 fatty acids Chemical class 0.000 abstract description 11
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 5
- 238000012136 culture method Methods 0.000 abstract description 2
- 229940040461 lipase Drugs 0.000 description 56
- 235000011187 glycerol Nutrition 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 229940088598 enzyme Drugs 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000009257 reactivity Effects 0.000 description 9
- 241000589516 Pseudomonas Species 0.000 description 8
- 239000013504 Triton X-100 Substances 0.000 description 8
- 229920004890 Triton X-100 Polymers 0.000 description 8
- 241000588881 Chromobacterium Species 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000235527 Rhizopus Species 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000000108 ultra-filtration Methods 0.000 description 5
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 4
- 102100022119 Lipoprotein lipase Human genes 0.000 description 4
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 4
- 235000011130 ammonium sulphate Nutrition 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- IEORSVTYLWZQJQ-UHFFFAOYSA-N 2-(2-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=CC=C1OCCO IEORSVTYLWZQJQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002271 DEAE-Sepharose Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920000847 nonoxynol Polymers 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 2
- 102000057621 Glycerol kinases Human genes 0.000 description 2
- 108700016170 Glycerol kinases Proteins 0.000 description 2
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 2
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 241000179532 [Candida] cylindracea Species 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- -1 etc. Chemical compound 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002523 gelfiltration Methods 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 235000019626 lipase activity Nutrition 0.000 description 2
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 2
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000012521 purified sample Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 102000013392 Carboxylesterase Human genes 0.000 description 1
- 108010051152 Carboxylesterase Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000000019 Sterol Esterase Human genes 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- FBDWCTWJJMORIU-UHFFFAOYSA-N magnesium;hexahydrate Chemical compound O.O.O.O.O.O.[Mg] FBDWCTWJJMORIU-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔発明の目的〕
産業上の利用分野
本発明は新規なリパーゼおよびその製造法に関する。本
発明のリパーゼはトリグリセライドの分解、特に好まし
くは血清中のトリグリセライドの分解に用いられる。DETAILED DESCRIPTION OF THE INVENTION [Object of the Invention] Industrial Application Field The present invention relates to a novel lipase and a method for producing the same. The lipase of the present invention is used for the decomposition of triglycerides, particularly preferably for the decomposition of triglycerides in serum.
従来の技術
血清などの生体体液試料中に存在するトリグリセライド
を酵素リパーゼで分解し、遊離した脂肪酸またはグリセ
ロールを定量することによってトリグリセライドを測定
する方法が知られているが実用に供されている方法はほ
とんどがグリセロールを定量する方法である。この目的
のため最初に用いられたリパーゼは動物の膵臓に由来す
るりパ−ゼであった。しかしこの酵素はトリグリセライ
ドを完全には分解できなかった。血清中のトリグリセラ
イドを酵素により完全に分解するため微生物を起源とす
るリパーゼの検索、性質の異なるリパーゼの組み合わせ
による分解、リパーゼと化学的薬剤の組み合わせによる
分解が研究された。例えば、リゾープス・アリザス(R
hizopus arrhizus )のリパーゼ(特
公昭59−15638、特開昭52−25693)、シ
ュードモナス(Pseudomonas )属のリパー
ゼ(特開昭49−50990.同49−69186、同
49−89596、同49−113695 、同57−
58898) 、リパーゼとプロテアーゼの併用(特公
昭54−9518、特開昭53−114493 ’)、
リゾープス・アリザスのリパーゼ、ブタ肝臓由来のカル
ボキシルエステラーゼおよびアルカリ金属またはアルカ
リ土類金属のアルキル硫酸塩の組み合わせ(特開昭49
−64495) 、カンジダ(Candida )属の
リパーゼ、すい臓リパーゼおよび胆汁酸塩の組み合わせ
(特開昭52−11987) 、クロモバクテリウム(
Chromobacterium )属のリパーゼ(特
開昭51−68297、同51−74692、同57−
58898) 、リゾープス・アリザスのリパーゼとカ
ンジダ・シリンドラツセ(C,cylindracea
)のリパーゼの組み合わせ(特開昭52−25694、
特公昭56−29 ) 、カンジダ・ルゴーサ(Cor
ugosa )のリパーゼと界面活性剤の組み合わせ(
特公昭57−39158) 、リゾープス・アリザスの
リパーゼとシュードモナス・フルオレッセンス(P、
fluorescens)のリパーゼの組み合わせ(特
公昭57−28276) 、リゾープス属などのリパー
ゼとコレステロールエステラーゼの組み合わせ(特公昭
56−46799) 、リパーゼと界面活性剤。Conventional Technology It is known to measure triglycerides by decomposing triglycerides present in biological body fluid samples such as serum using the enzyme lipase and quantifying the released fatty acids or glycerol, but there are no methods that have been put to practical use. Most of these methods quantify glycerol. The first lipases used for this purpose were lipases derived from animal pancreas. However, this enzyme was unable to completely degrade triglycerides. In order to completely enzymatically decompose triglycerides in serum, researchers investigated lipases originating from microorganisms, decomposition using combinations of lipases with different properties, and decomposition using combinations of lipases and chemical agents. For example, Rhizopus alizas (R
hizopus arrhizus) lipase (JP 59-15638, JP 52-25693), Pseudomonas lipase (JP 49-50990, JP 49-69186, JP 49-89596, JP 49-113) 695, Same 57-
58898), combined use of lipase and protease (Japanese Patent Publication No. 54-9518, Japanese Patent Publication No. 53-114493'),
A combination of lipase from Rhizopus alizas, carboxylesterase derived from pig liver, and alkyl sulfate of an alkali metal or alkaline earth metal
-64495), a combination of Candida lipase, pancreatic lipase and bile salts (Japanese Patent Application Laid-Open No. 52-11987), Chromobacterium (
Lipase of the genus Chromobacterium (JP-A-51-68297, JP-A-51-74692, JP-A-57-
58898), Rhizopus alizas lipase and Candida cylindracea (C. cylindracea)
) combination of lipases (JP-A-52-25694,
Tokuko Sho 56-29), Candida rugosa (Cor
ugosa) lipase and surfactant combination (
Special Publication No. 57-39158), Lipase of Rhizopus alizas and Pseudomonas fluorescens (P.
fluorescens) lipase combination (Japanese Patent Publication No. 57-28276), combination of lipase such as Rhizopus and cholesterol esterase (Japanese Patent Publication No. 56-46799), lipase and surfactant.
フェノール誘導体若しくはアニリン誘導体の組み合わせ
(特公昭5B−5677)が知られている。A combination of phenol derivatives or aniline derivatives (Japanese Patent Publication No. 5B-5677) is known.
また、シュードモナス属のある種のものが、グリセロー
ル生成活性の脂肪酸生成活性に対する割合が1%以上の
リパーゼを生産する(特開昭59=187780)こと
も知られている。It is also known that certain species of the genus Pseudomonas produce lipases in which the ratio of glycerol-producing activity to fatty acid-producing activity is 1% or more (Japanese Patent Laid-Open No. 187780).
また、ペニシリウム属がリパーゼを産生ずることは公知
である。Iwaiらはペニシリウム・サイクロピウム・
ウェストリング(Penicillium cyclo
−pium Westring )株が2種のリパーゼ
を産生ずることを報告している(Agr、BiolCh
em、+ 1063−1070頁、第39巻、 198
0年)。彼等は又、ペニシリウム・サイクロピウムM1
株が2種のリパーゼを産生ずることを報告している(J
、Biochem、+ 205−211頁、第87巻、
1980年)。It is also known that Penicillium species produce lipase. Iwai et al.
Waist ring (Penicillium cyclo)
-pium Westring) strain produces two types of lipases (Agr, BiolCh
em, + pp. 1063-1070, Volume 39, 198
0 years). They also have Penicillium Cyclopium M1
reported that the strain produces two types of lipase (J
, Biochem, + pages 205-211, Volume 87,
(1980).
発明が解決しようとする問題点
上述した血清中のトリグリセライドの分解に関する先行
技術において、単独で用いられた微生物由来のリパーゼ
は依然としてトリグリセライドを十分に分解することが
できないか、または分解速度が緩やかであった。あるい
は、これらのリパーゼはトリグリセライド測定用試薬組
成物に含まれる界面活性剤により活性が阻害されるとい
う欠点があった。また、起源の異なる複数のリパーゼを
組み合わせて用いる場合はその製造がやっかいである。Problems to be Solved by the Invention In the prior art related to the decomposition of triglycerides in serum as described above, lipases derived from microorganisms used alone are still unable to sufficiently decompose triglycerides or the rate of decomposition is slow. Ta. Another drawback of these lipases is that their activity is inhibited by the surfactant contained in the reagent composition for triglyceride measurement. Furthermore, when multiple lipases from different origins are used in combination, the production is complicated.
本発明はこれらの問題を解決して、単独で用いても十分
にトリグリセライドを分解することができ、且つトリグ
リセライドの測定において脂肪の乳化に用いられる界面
活性剤、例えばポリエチレングリコールアルキルフェニ
ルエーテル系などの界面活性剤による活性の阻害を実質
的に受けることのない新規なリパーゼおよびその製造法
を提供することを目的とする。The present invention solves these problems and uses surfactants such as polyethylene glycol alkyl phenyl ether, which can sufficiently decompose triglycerides even when used alone, and which are used to emulsify fat in the measurement of triglycerides. The object of the present invention is to provide a novel lipase whose activity is not substantially inhibited by surfactants and a method for producing the same.
問題点を解決するための手段
本発明によれば、トリグリセライドに作用し、グリセロ
ール生成活性の脂肪酸生成活性に対する割合が5%以上
であり界面活性剤により活性化され、その濃度が少なく
とも5%以下の範囲において活性が実質的に阻害されな
いという性質を有する新規リパーゼおよびその製造法が
提供される。Means for Solving the Problems According to the present invention, a surfactant that acts on triglycerides, has a ratio of glycerol-generating activity to fatty acid-generating activity of 5% or more, is activated by a surfactant, and has a concentration of at least 5% or less. Provided are a novel lipase whose activity is not substantially inhibited within this range, and a method for producing the same.
本発明のリパーゼはペニシリウム厘に属する菌株の培養
によって得られる。ペニシリウム属に属し本発明のリパ
ーゼを産生ずる菌株としては、特に好ましくはペニシリ
ウム・サイクロピウムATCC34613(Penic
illium cyclopium ATCC34
613) が挙げられる。The lipase of the present invention can be obtained by culturing a strain belonging to Penicillium genus. As a strain that belongs to the genus Penicillium and produces the lipase of the present invention, particularly preferred is Penicillium cyclopium ATCC 34613 (Penicillium cyclopium ATCC 34613).
illium cyclopium ATCC34
613).
ペニシリウム・サイクロピウムATCC34613ハ少
なくとも3種類の異なる性質のリパーゼを生産すること
を確認した。本発明のリパーゼはそのうちの一つで前述
した公知の2種とは明らかに異なる新規なリパーゼであ
る。本発明のリパーゼは以下に示す理化学的性質を示す
。It was confirmed that Penicillium cyclopium ATCC 34613 produces at least three types of lipases with different properties. The lipase of the present invention is one of them, and is a novel lipase that is clearly different from the two known types mentioned above. The lipase of the present invention exhibits the following physicochemical properties.
(1)作用ニ
トリグリセライドに作用し、グリセロール生成活性の脂
肪酸生成活性に対する割合が5%以上である。(1) Action: Acts on nitriglycerides, and the ratio of glycerol production activity to fatty acid production activity is 5% or more.
(2)基質特異性:
炭素数4〜18の脂肪酸のトリグリセライドをよく分解
する。(2) Substrate specificity: Easily decomposes triglycerides of fatty acids having 4 to 18 carbon atoms.
(3)至適pHの範囲: pH5〜7(第1図に示す)
(4)安定pi(の範囲:
pH3〜8において、37℃、30分間処理した後残存
活性を測定したところ、約4.5〜6のpHの範囲で安
定であった(第2図に示す)。(3) Optimal pH range: pH 5 to 7 (shown in Figure 1)
(4) Stable pi (range: pH 3 to 8, after treatment at 37°C for 30 minutes, residual activity was measured, and it was found to be stable in the pH range of approximately 4.5 to 6 (as shown in Figure 2). ).
(5)作用通温の範囲:35〜40℃(第3図に示す)
(6)温度安定性:
pH7,0において、0〜50℃の各温度で30分間処
理した後、残存活性を測定したところ、約35℃まで安
定であった(第4図に示す)。(5) Range of action heating: 35-40℃ (shown in Figure 3)
(6) Temperature stability: At pH 7.0, residual activity was measured after treatment at each temperature of 0 to 50°C for 30 minutes, and it was found to be stable up to about 35°C (shown in Figure 4).
(7)阻害、活性化および安定化:
界面活性剤により活性化され、その濃度が少なくとも5
%以下の範囲において実質的に活性が阻害されない。(7) Inhibition, activation and stabilization: activated by surfactants and whose concentration is at least 5
% or less, the activity is not substantially inhibited.
(8)分子量:約110,000 (セファデックス
G−100を用いたゲルろ適法による)
(9)等電点: pH3,84(アンホラインを用いた
等電点電気泳動法による)
(10)結晶形:菱形、板状
本発明のリパーゼのトリグリセライドに対する反応性を
、公知のシュードモナス属由来のリパーゼ(商標名:リ
ボプロティンリパーゼ・タイプA、東洋紡績社製)およ
びクロモバクテリウム属由来のリパーゼ(東洋醸造社製
)と対比して第1表に示す。(8) Molecular weight: Approximately 110,000 (by gel filtration method using Sephadex G-100) (9) Isoelectric point: pH 3,84 (by isoelectric focusing method using Ampholine) (10) Crystal Shape: rhombus, plate The reactivity of the lipase of the present invention to triglycerides was determined using known lipases derived from the genus Pseudomonas (trade name: Riboprotein Lipase Type A, manufactured by Toyobo Co., Ltd.) and lipases derived from the genus Chromobacterium (Toyobo Co., Ltd.). Table 1 shows the results in comparison with those manufactured by Jozo Co., Ltd.).
(以下余白)
第1表
本発明のリパーゼと前述の公知のリパーゼは界面活性剤
に対する感受性および脂肪酸とグリセロールの生成速度
の点で最も異なる。即ち、本発明のリパーゼは約5%と
いう高濃度の界面活性剤の存在下でも実質的に活性阻害
を受けることがないくまた、速やかにグリセロールを生
成するという性質を有する。この性質はリパーゼを血清
中のトリグリセライドの分解に用いる場合に有用である
。(The following is a blank space) Table 1 The lipase of the present invention and the above-mentioned known lipase differ most in sensitivity to surfactants and production rate of fatty acids and glycerol. That is, the lipase of the present invention has the property that its activity is not substantially inhibited even in the presence of a surfactant at a high concentration of about 5%, and it rapidly produces glycerol. This property is useful when lipase is used to degrade triglycerides in serum.
本発明において、ペニシリウム属菌株の培養は、糸状菌
の一般的な培養方法により行われる。例えば、栄養培地
としては、ペニシリウム属菌株が資化し得る炭素源、窒
素源および無機物などを含む合成培地または天然培地が
用いられる。炭素源としてはグルコース、フラクトース
、マルトース、シュクロース、糖蜜、澱粉、デキストリ
ン、有機酸およびグリセリンなどが使用される。窒素源
としては麦芽エキス、ペプトン、酵母エキス、乾燥酵母
、肉エキス、コーンスチープリカー、カゼイン、アミノ
酸などの有機窒素源、および硝酸塩、アンモニウム塩な
どの無機窒素源が使用される。In the present invention, the Penicillium genus strain is cultured by a general culture method for filamentous fungi. For example, as the nutrient medium, a synthetic medium or a natural medium containing a carbon source, a nitrogen source, inorganic substances, etc. that can be assimilated by Penicillium strains is used. Glucose, fructose, maltose, sucrose, molasses, starch, dextrin, organic acids, glycerin, and the like are used as carbon sources. As nitrogen sources, organic nitrogen sources such as malt extract, peptone, yeast extract, dried yeast, meat extract, corn steep liquor, casein, amino acids, and inorganic nitrogen sources such as nitrates and ammonium salts are used.
無機物としてはカリウム、ナトリウム、マグネシウム、
カルシウム、亜鉛、鉄などの無機塩が必要に応じて使用
される。培養中の発泡を抑えるために、界面活性剤、シ
リコン、植物油などの消泡剤を添加することもできる。Inorganic substances include potassium, sodium, magnesium,
Inorganic salts such as calcium, zinc, iron, etc. are used as necessary. Antifoaming agents such as surfactants, silicones, and vegetable oils can also be added to suppress foaming during culture.
培養は、通常振盪または通気攪拌下好気的条件のもとに
おこなうのがよい。培養温度、培地のpHなどの培養条
件は菌が生育しリパーゼが産生される範囲内であればい
ずれの条件でもよい。Cultivation is usually carried out under aerobic conditions with shaking or aeration. The culture conditions, such as culture temperature and pH of the medium, may be any conditions as long as they are within the range in which the bacteria can grow and lipase can be produced.
以上のようにして得られた培養物から本発明のリパーゼ
を採取するには、その理化学的性質を利用して、公知の
蛋白質の精製法を適宜組み合わせて行うことができる。The lipase of the present invention can be collected from the culture obtained as described above by appropriately combining known protein purification methods by taking advantage of its physicochemical properties.
例えば、培養物をろ過もしくは遠心分離して菌体を除い
たのち、硫安、硫酸ナトリウムなどを用いた塩析、エタ
ノール、メタノール、アセトンなどを用いた有機溶媒沈
澱、活性炭、シリカゲル、アルミナ、ヒドロキシアパタ
イト、セルロースなどを用いた吸着クロマトグラフィー
、イオン交換樹脂、イオン交換セルロース、イオン交換
セファデックスなどを用いたイオン交換クロマトグラフ
ィー、セファデックス、バイオゲルなどを用いたゲルろ
過および電気泳動、限外ろ過、透析などの公知の方法を
任意の順序で適宜組み合せ、または繰り返すことにより
精製する。For example, after removing bacterial cells by filtering or centrifuging the culture, salting out using ammonium sulfate, sodium sulfate, etc., organic solvent precipitation using ethanol, methanol, acetone, etc., activated carbon, silica gel, alumina, hydroxyapatite, etc. , adsorption chromatography using cellulose, ion exchange chromatography using ion exchange resin, ion exchange cellulose, ion exchange Sephadex, etc., gel filtration and electrophoresis using Sephadex, biogel, etc., ultrafiltration, dialysis. Purification is carried out by appropriately combining or repeating known methods such as in any order.
本発明において、リパーゼ活性の表示は、基質オリーブ
オイル乳化液に37℃においてリパーゼを作用させたと
き、1分間に1マイクロ当量のグリセロールを生成する
量を1単位とした。In the present invention, lipase activity is expressed as 1 unit, which is the amount of 1 microequivalent of glycerol produced per minute when lipase is allowed to act on the substrate olive oil emulsion at 37°C.
酵素活性測定法
1)グリセロール生成活性
オリーブ油乳化液を基質に、生成するグリセロールを酵
素法で測定する。Enzyme activity measurement method 1) Glycerol production activity Glycerol produced is measured by an enzymatic method using an olive oil emulsion as a substrate.
(1)試薬
a)基質ニオリーブ油(半井化学製)10g、トリトン
X −10010g 、精製水30r11!を攪拌子を
用い30分間攪拌乳化する。次いでこれに10%牛血清
アルブミン(フラクション■)を含む50mM IJン
酸緩衝液(pH6,5)を20−を添加混合する。(1) Reagent a) Substrate Niolive oil (manufactured by Hanui Chemical Co., Ltd.) 10g, Triton X-10010g, purified water 30r11! Stir and emulsify for 30 minutes using a stirrer. Next, 50mM IJ acid buffer (pH 6.5) containing 10% bovine serum albumin (fraction ■) was added and mixed.
b)グリセロール測定試薬:100−のMES(2−(
N−モノホリノ)エタン−スルホン酸〕緩衝液(pH6
,5)に下記の試薬を溶解する。b) Glycerol measurement reagent: 100-MES (2-(
N-monopholino)ethane-sulfonic acid] buffer (pH 6
, 5) dissolve the following reagents.
トリトンX−1000,1g、 N−エチル−N−(2
−ヒドロキシ−3−スルホプロピル)−m−)ルビジン
64.6■、4−アミノアンチピリン 10.2■、E
DTA・2ナトリウム 37.2■、アデノシン酸リン
酸・2ナトリウム200■、塩化マグネシウム・6水塩
40.7■、グリセロールキナーゼ 50単位、グリ
セロリン酸オキシダーゼ400単位、ペルオキシダーゼ
200単位。Triton X-1000, 1g, N-ethyl-N-(2
-Hydroxy-3-sulfopropyl)-m-) Rubidine 64.6■, 4-aminoantipyrine 10.2■, E
DTA disodium 37.2■, adenosinate phosphate disodium 200■, magnesium chloride hexahydrate 40.7■, glycerol kinase 50 units, glycerophosphate oxidase 400 units, peroxidase 200 units.
(2)操作
基質1.0−を試験管にとり37℃で予備加温する。こ
れに希釈酵素液0.1rI11を加え反応を開始する。(2) Manipulation Place 1.0- of the substrate in a test tube and prewarm it at 37°C. Add 0.1rI11 of the diluted enzyme solution to this to start the reaction.
37℃で15分間反応後、0.2M トリクロル酢酸液
2.0m1を加え反応を停止する。反応停止液を東洋ろ
紙(m 131)を用いてろ過する。ろ液0.02mf
をグリセロール測定試薬3−中に加え、37°Cで10
分間加温し555nmにおける吸光度を測定する。After reacting at 37°C for 15 minutes, 2.0 ml of 0.2M trichloroacetic acid solution was added to stop the reaction. The reaction stop solution is filtered using Toyo filter paper (m131). Filtrate 0.02mf
was added to glycerol measurement reagent 3- and incubated at 37°C for 10
Heat for a minute and measure absorbance at 555 nm.
(3)活性表示
1分間に1マイクロモルのグリセロールを生成する酵素
量を1単位とした。(3) Activity display The amount of enzyme that produces 1 micromole of glycerol per minute was defined as 1 unit.
2)脂肪酸生成活性
オリーブ油乳化液を基質に、生成する脂肪酸を水酸化ナ
トリウム溶液で滴定し測定する。2) Fatty acid production activity Using the olive oil emulsion as a substrate, the fatty acids produced are measured by titration with a sodium hydroxide solution.
(1)操作
上記基質1.0mt’を試験管にとり、37℃で予備加
温する。これに希釈酵素液0.1−を加え反応を開始す
る。37°Cで15分間反応後、2.5mf’のエタノ
ール−アセトン混液(1:1)を加え反応を停止する。(1) Procedure Place 1.0 mt' of the above substrate in a test tube and prewarm it at 37°C. Add 0.1 - of the diluted enzyme solution to this to start the reaction. After reacting at 37°C for 15 minutes, 2.5 mf' of an ethanol-acetone mixture (1:1) was added to stop the reaction.
指示薬としてフェノールフタレインを数滴加え1/20
M水酸化ナトリウムで滴定する。Add a few drops of phenolphthalein as an indicator and add 1/20
Titrate with M sodium hydroxide.
(2)活性表示
1分間に1マイクロモルの脂肪酸を生成する酵素量を1
単位とした。(2) Activity display The amount of enzyme that produces 1 micromole of fatty acids per minute is 1
It was taken as a unit.
実施例1
米糠2%、コーンスチーブリ力−1,5%からなる培地
(pH6,0) 20jl!の入ったジャーファーメン
タ−にペニシリウム・サイクロピウム^TCC3461
3を接種し、25℃において24時間培養して種培養液
とした。上記と同じ組成の培地が5001入った発酵槽
に種培養液を接種し、25℃において40時間培養した
。培養液をろ過して菌体を除き、得られたろ液を限外ろ
過により濃縮した。濃縮液に硫酸アンモニウムを75%
飽和に加え、生成した沈澱を集め10mMリン酸緩衝液
(pH7,0) 201に溶解した。Example 1 Culture medium (pH 6.0) consisting of 2% rice bran and 1.5% corn stewley strength 20jl! Penicillium cyclopium in a jar containing ^TCC3461
3 was inoculated and cultured at 25°C for 24 hours to prepare a seed culture. The seed culture solution was inoculated into a fermenter containing 500ml of a medium with the same composition as above, and cultured at 25°C for 40 hours. The culture solution was filtered to remove bacterial cells, and the resulting filtrate was concentrated by ultrafiltration. 75% ammonium sulfate in concentrate
In addition to saturation, the generated precipitate was collected and dissolved in 10 mM phosphate buffer (pH 7,0) 201.
この溶液を限外ろ過により脱塩した後、あらかじめ同緩
衝液で平衡化したDEAE−セルロース2 k+rを加
えた。同緩衝液30/を用いてDEAE−セルロースを
洗浄した後、0.25M塩化ナトリウムを含む同緩衝液
を加え、得られた溶出液を限外ろ過により脱塩、濃縮し
た。この液をあらかじめ10mMリン酸緩衝液(pH7
,0)で平衡化したDEAE−セファロース(ファルマ
シア社製)を充填したカラムに通した。カラムを0.1
M塩化ナトリウムを含む同緩衝液で洗浄した後、塩化ナ
トリウムの濃度を0.1〜0.25Mに上げる直線濃度
勾配法により溶出を行った。リパーゼ活性は3つのピー
クに分かれた(第5図に示す)。第2の活性ピークの両
分を集めて硫安堰折に付し、55%飽和から75%飽和
の範囲で生成した沈澱を集めた。沈澱を10mMリン酸
緩衝液(p)l 7.0)に熔解し、限外ろ過により脱
塩した後、凍結乾燥を行うことにより精製リパーゼ標品
を得た。この精製標品をハイドロキシアパタイトを用い
たカラムクロマトグラフィーに付した後、硫安溶液より
結晶化を行った。結晶形は菱形、板状であった。After desalting this solution by ultrafiltration, DEAE-cellulose 2k+r equilibrated in advance with the same buffer was added. After washing DEAE-cellulose with the same buffer solution 30/, the same buffer solution containing 0.25M sodium chloride was added, and the obtained eluate was desalted and concentrated by ultrafiltration. This solution was mixed in advance with 10mM phosphate buffer (pH 7).
The mixture was passed through a column packed with DEAE-Sepharose (manufactured by Pharmacia) equilibrated with . column to 0.1
After washing with the same buffer containing M sodium chloride, elution was performed by a linear concentration gradient method in which the concentration of sodium chloride was increased from 0.1 to 0.25M. Lipase activity was divided into three peaks (shown in Figure 5). Both parts of the second active peak were collected and subjected to ammonium sulfate weir fractionation, and the precipitate produced in the range of 55% saturation to 75% saturation was collected. The precipitate was dissolved in 10 mM phosphate buffer (p)l 7.0), desalted by ultrafiltration, and then freeze-dried to obtain a purified lipase preparation. This purified sample was subjected to column chromatography using hydroxyapatite, and then crystallized from ammonium sulfate solution. The crystal shape was rhombic and plate-like.
上記で得られた精製標品は、比活性が9.2U/■蛋白
であり、培養液から約130倍に精製され、収率は約1
7%であった。The purified sample obtained above has a specific activity of 9.2 U/■ protein, is purified approximately 130 times from the culture solution, and has a yield of approximately 1
It was 7%.
参考例1
実施例1において、DEAE−セファロースカラムクロ
マトグラフィーで得られた第1および第3の活性ピーク
の両分をそれぞれさらに精製した。Reference Example 1 In Example 1, both the first and third active peaks obtained by DEAE-Sepharose column chromatography were further purified.
第1の活性ピークから得られた標品は、トリブチリンに
よく作用し、脂肪酸のメチルエステルに対する作用は弱
いという性質を示し、第3の活性ピークから得られた標
品は、脂肪酸のモノグリセライドにはよく作用するが、
トリグリセライドに対する作用は弱いという性質を示し
た。これらの性質は前掲の先行技術に開示されたリパー
ゼに相当するものである。The sample obtained from the first activity peak has a strong effect on tributyrin and weak effect on fatty acid methyl esters, while the sample obtained from the third activity peak has a strong effect on tributyrin and weak effect on fatty acid monoglycerides. It works well, but
The effect on triglycerides was weak. These properties correspond to the lipases disclosed in the prior art cited above.
参考例2
本発明のリパーゼを血清脂質に作用せしめ、生成したグ
リセロールを測定することによりリパーゼの脂質への反
応性をみた。Reference Example 2 The reactivity of lipase to lipids was examined by allowing the lipase of the present invention to act on serum lipids and measuring the produced glycerol.
即ち、0.5U/−グリセロールキナーゼ、4U/−α
−グリセロホスフェートオキシダーゼ、2U/−ペルオ
キシダーゼ、3.3mMアデノシン三リン酸、0.5m
M4−アミノアンチピリン、2.0mM TOO3(
N−エチル−N−(2−ヒドロキシ−3−スルホプロピ
ル) −m−)ルイジン) 、2 mMi化マグネシウ
ム・6水塩、0.5U/−の本発明のリパーゼ、および
0.05〜5.0%の範囲の濃度のポリエチレングリコ
ールp−イソオクチルフェニルエーテル(商標名ニトリ
トンX −100,Rohm & Haas社製)を含
む0.1M−P I PEI緩衝液(pl+ 6.5)
1.0−と標準血清試料(商標:リピツドセーラム■”
栄研”、栄研化学社製) 0.01−を混合し、37℃
において10分間インキエベートした。反応液の555
nmにおける吸光度を測定し、試料中のトリグリセラ
イド(トリオレイン換算)濃度を算出した。i.e. 0.5U/-glycerol kinase, 4U/-α
- Glycerophosphate oxidase, 2U/- peroxidase, 3.3mM adenosine triphosphate, 0.5m
M4-aminoantipyrine, 2.0mM TOO3 (
N-ethyl-N-(2-hydroxy-3-sulfopropyl)-m-)luidine), 2 mM magnesium hexahydrate, 0.5 U/- of the lipase of the present invention, and 0.05 to 5. 0.1 M P I PEI buffer (pl+ 6.5) containing polyethylene glycol p-isooctylphenyl ether (trade name Nitriton X-100, manufactured by Rohm & Haas) in a concentration range of 0%
1.0- and standard serum sample (trademark: Lipid Serum ■”
Eiken”, manufactured by Eiken Chemical Co., Ltd.) 0.01- and heated to 37°C.
Incubate for 10 minutes. 555 of reaction solution
The absorbance at nm was measured, and the triglyceride (triolein equivalent) concentration in the sample was calculated.
使用したトリトンX −100の濃度と測定値を第2表
に示す。本発明の酵素は、5%という高濃度の界面活性
剤によっても活性が阻害されないことが分かる。The concentration and measured values of Triton X-100 used are shown in Table 2. It can be seen that the activity of the enzyme of the present invention is not inhibited even by a surfactant at a high concentration of 5%.
第2表
参考例3
0.5 U/rn1グリセロールキナーゼ、4U/+n
eα−グリセロホスフエートオキシダーゼ、2U/ml
ペルオキシダーゼ、3.3mMアデノシン三リン酸、0
.5mM4−アミノアンチピリン、2.0mM TO
O3,2mM塩化マグネシウム・6水塩、および0.1
〜1.0%の濃度のトリトンX −100を含む0.1
M−P I PES緩衝液(pfl 6.5) 1.0
−と25U/−の本発明のリパーゼ0.02−を混合し
、37℃において5分間インキニベートした。次いで、
血清試料0.011n1を添加し、経時的に555 n
mにおける吸光度を測定した。Table 2 Reference Example 3 0.5 U/rn1 glycerol kinase, 4U/+n
eα-glycerophosphate oxidase, 2U/ml
Peroxidase, 3.3mM adenosine triphosphate, 0
.. 5mM 4-aminoantipyrine, 2.0mM TO
O3, 2mM magnesium chloride hexahydrate, and 0.1
0.1 containing Triton X-100 at a concentration of ~1.0%
M-PI PES buffer (pfl 6.5) 1.0
- and 25 U/- of the lipase of the present invention 0.02- were mixed and incubated for 5 minutes at 37°C. Then,
Serum sample 0.011n1 was added and 555nl was added over time.
The absorbance at m was measured.
トリトンX −100の濃度とリパーゼの反応性ノ関係
を第6図に示す。本発明の酵素はトリトンX−100に
よって活性化され、その効果は0.1〜1.0%の範囲
においてほとんど変わらないことが分かる。The relationship between the concentration of Triton X-100 and the reactivity of lipase is shown in FIG. It can be seen that the enzyme of the present invention is activated by Triton X-100, and its effect hardly changes in the range of 0.1 to 1.0%.
比較例1
各種リパーゼのグリセロール生成活性と脂肪酸生成活性
を測定したところ、本酵素はシュードモナス属(東洋紡
績社、大野製薬社製)、クロモバクテリウム属(東洋醸
造社製)由来の市販リパーゼに比べ、脂肪酸生成活性に
対し、グリセロール生成活性が著しく高い特性を有する
。Comparative Example 1 When the glycerol production activity and fatty acid production activity of various lipases were measured, this enzyme was found to be superior to commercially available lipases derived from the genus Pseudomonas (manufactured by Toyobo Co., Ltd., Ohno Pharmaceutical Co., Ltd.) and chromobacterium genus (manufactured by Toyo Jozo Co., Ltd.). , has a characteristic that glycerol production activity is significantly higher than fatty acid production activity.
(以下余白)
第3表
比較例2
参考例3において、本発明のリパーゼに代えて市販のシ
ュードモナス属由来のリパーゼ(商標名: LPL″
Amano″■、大野製薬社製)、クロモバクテリウム
属由来のリパーゼ(東洋醸造社製)またはシュードモナ
ス属由来のリパーゼ(商標名:リボプロティンリパーゼ
・タイプA、東洋紡績社製)をそれぞれ表示活性で50
U/me、100U/艷および0.2U/−用いた以外
は同様に操作した。(Margin below) Table 3 Comparative Example 2 In Reference Example 3, a commercially available lipase derived from Pseudomonas (trade name: LPL'') was used instead of the lipase of the present invention.
Amano''■, manufactured by Ohno Pharmaceutical Co., Ltd.), lipase derived from Chromobacterium (manufactured by Toyo Jozo Co., Ltd.), or lipase derived from Pseudomonas genus (trade name: riboprotein lipase type A, manufactured by Toyobo Co., Ltd.) with the indicated activity. 50
The same procedure was carried out except that U/me, 100 U/min and 0.2 U/min were used.
トリトンX −100の濃度と各リパーゼの反応性の関
係を第7図A〜第7図Cに示す。第7図AはLPL″A
mano”■、第7図Bはクロモバクテリウム属由来の
リパーゼ、第7図Cはリボプロティンリパーゼ・タイプ
Aをそれぞれ用いた場合を表す。The relationship between the concentration of Triton X-100 and the reactivity of each lipase is shown in FIGS. 7A to 7C. Figure 7 A is LPL″A
Fig. 7B shows the case where lipase derived from Chromobacterium genus is used, and Fig. 7C shows the case where riboprotein lipase type A is used.
これら公知の酵素は、いずれもトリトンX −100の
濃度が高くなるにしたがい活性が阻害されることがわか
る。It can be seen that the activity of all of these known enzymes is inhibited as the concentration of Triton X-100 increases.
参考例4
参考例3において、トリトンX −100に代えて0.
1〜0.5%のノニルフェノールエトキシレート系界面
活性剤(商標名ニアデカトールNP−700、旭電化社
製)または0.1〜0.5%の第2級直鎖アルコールエ
トキシレート系界面活性剤(商標名ニアデカトールSo
、135、旭電化社製)を用いた以外は同様に操作した
。Reference Example 4 In Reference Example 3, Triton X-100 was replaced with 0.
1 to 0.5% nonylphenol ethoxylate surfactant (trade name Niadecatol NP-700, manufactured by Asahi Denka Co., Ltd.) or 0.1 to 0.5% secondary linear alcohol ethoxylate surfactant ( Trade name: Niadecatol So
, 135, manufactured by Asahi Denka Co., Ltd.) was used.
界面活性剤の濃度と本発明のリパーゼの反応性の関係を
第8図および第9図に示す。第8図および第9図はそれ
ぞれノニルフェノールエトキシレート系界面活性剤およ
び第2級直鎖アルコールエトキシレート系界面活性剤を
用いた場合を表す。The relationship between the concentration of surfactant and the reactivity of the lipase of the present invention is shown in FIGS. 8 and 9. FIG. 8 and FIG. 9 show the case where a nonylphenol ethoxylate surfactant and a secondary linear alcohol ethoxylate surfactant are used, respectively.
本発明の酵素はこれらの界面活性剤によって実質的に阻
害されないことが分かる。It can be seen that the enzymes of the invention are not substantially inhibited by these surfactants.
本発明によれば、新規なリパーゼおよびその製造法が提
供される。本発明のリパーゼは血清中のトリグリセライ
ドをほぼ完全に分解し、かつ高濃度の界面活性剤によっ
ても実質的に活性阻害を受けることがないため、トリグ
リセライドの測定に極めて有用である。According to the present invention, a novel lipase and a method for producing the same are provided. The lipase of the present invention almost completely decomposes triglycerides in serum, and its activity is not substantially inhibited even by high concentrations of surfactants, so it is extremely useful for measuring triglycerides.
第1図は本発明のリパーゼの至適pHの範囲を表す図で
あり、同じく第2.3.4図はそれぞれ安定pHの範囲
、作用適温の範囲および温度安定性を表す図である。
第5図は、ペニシリウム・サイクロピウムATCC34
613の産生する3種のリパーゼのDEAE−セファロ
ースによるカラムクロマトグラフィーのパターンを表す
図である。
第6図は、トリトンX −100の濃度と本発明のリパ
ーゼの反応性の関係を表す図である。同じく第7図Aは
シュードモナス属由来のリパーゼ(LPL” Aman
o”■)、第7図Bはクロモバクテリウム属由来のリパ
ーゼ、第7図Cはシュードモナス属由来のリパーゼ(リ
ポプロティンリパーゼ・タイプA)の反応性を表す図で
ある。
第8図は、ノニルフェノールエトキシレート系界面活性
剤の濃度と本発明のリパーゼの反応性の関係を表す図で
あり、同じ(第9図は、第2級直鎖アルコールエトキシ
レート系界面活性剤の濃度と反応性の関係を表す図であ
る。Figure 1 is a diagram showing the optimal pH range of the lipase of the present invention, and Figures 2.3.4 are diagrams showing the stable pH range, optimal action temperature range, and temperature stability, respectively. Figure 5 shows Penicillium Cyclopium ATCC34
613 is a diagram showing column chromatography patterns of three types of lipase produced by DEAE-Sepharose. FIG. 6 is a diagram showing the relationship between the concentration of Triton X-100 and the reactivity of the lipase of the present invention. Similarly, FIG. 7A shows lipase derived from the genus Pseudomonas (LPL" Aman
Fig. 7B shows the reactivity of lipase derived from the genus Chromobacterium, and Fig. 7C shows the reactivity of the lipase derived from the genus Pseudomonas (lipoprotein lipase type A). FIG. 9 is a diagram showing the relationship between the concentration of a nonylphenol ethoxylate surfactant and the reactivity of the lipase of the present invention. It is a diagram showing relationships.
Claims (1)
性の脂肪酸生成活性に対する割合が5%以上であり、界
面活性剤により活性化され、その濃度が少なくとも5%
以下の範囲において実質的に活性が阻害されない性質を
有するリパーゼ。 2 界面活性剤が非イオン性界面活性剤である特許請求
の範囲第1項記載のリパーゼ。 3 非イオン性界面活性剤がポリエチレングリコールア
ルキルエーテル系の界面活性剤である特許請求の範囲第
2項記載のリパーゼ。 4 ペニシリウム属に属し、トリグリセライドによく作
用しグリセロール生成活性の脂肪酸生成活性に対する割
合が5%以上であり界面活性剤により活性化され、その
濃度が少なくとも5%以下の範囲において実質的に活性
が阻害されない性質を有するリパーゼを産生する菌株を
培養し得られた培養物から当該リパーゼを採取すること
を特徴とするリパーゼの製造法。 5 ペニシリウム属に属する菌株がペニシリウム・サイ
クロピウムである特許請求の範囲第4項記載のリパーゼ
の製造法。[Claims] 1. A substance that acts well on triglycerides, has a ratio of glycerol-generating activity to fatty acid-generating activity of 5% or more, is activated by a surfactant, and has a concentration of at least 5%.
A lipase whose activity is not substantially inhibited within the following range. 2. The lipase according to claim 1, wherein the surfactant is a nonionic surfactant. 3. The lipase according to claim 2, wherein the nonionic surfactant is a polyethylene glycol alkyl ether surfactant. 4 Belongs to the genus Penicillium, acts well on triglycerides, has a ratio of glycerol-generating activity to fatty acid-generating activity of 5% or more, is activated by surfactants, and is substantially inhibited when its concentration is at least 5% or less. 1. A method for producing lipase, which comprises culturing a strain that produces a lipase having properties that do not affect the production of lipase, and collecting the lipase from the resulting culture. 5. The method for producing lipase according to claim 4, wherein the strain belonging to the genus Penicillium is Penicillium cyclopium.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8299186A JPS62239990A (en) | 1986-04-10 | 1986-04-10 | Novel lipase and production thereof |
US07/034,452 US4999289A (en) | 1986-04-10 | 1987-04-06 | Lipase, its production and use for assay of triglycerides |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8299186A JPS62239990A (en) | 1986-04-10 | 1986-04-10 | Novel lipase and production thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62239990A true JPS62239990A (en) | 1987-10-20 |
JPH0544274B2 JPH0544274B2 (en) | 1993-07-05 |
Family
ID=13789687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8299186A Granted JPS62239990A (en) | 1986-04-10 | 1986-04-10 | Novel lipase and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62239990A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219744A (en) * | 1987-08-26 | 1993-06-15 | Ajinomoto Co., Inc. | Process for modifying fats and oils |
-
1986
- 1986-04-10 JP JP8299186A patent/JPS62239990A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5219744A (en) * | 1987-08-26 | 1993-06-15 | Ajinomoto Co., Inc. | Process for modifying fats and oils |
Also Published As
Publication number | Publication date |
---|---|
JPH0544274B2 (en) | 1993-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sugiura et al. | Purification, crystallization and properties of triacylglycerol lipase from Pseudomonas fluorescens | |
US4056442A (en) | Lipase composition for glycerol ester determination | |
US5232846A (en) | Method for producing a thermostable lipoprotein lipase from streptomyces | |
US4999289A (en) | Lipase, its production and use for assay of triglycerides | |
US4283494A (en) | Microbial lipase, process for its preparation and microbiologically pure culture therefor | |
Aisaka et al. | Production of lipoprotein lipase and lipase by Rhizopus japonicus | |
FR2508487A1 (en) | ASSAY METHOD FOR LIPID-RELATED COMPONENT, COMPOSITION FOR ASSAY AND PROCESS FOR PRODUCTION OF ENZYME USED THEREFOR | |
US4677062A (en) | Process for producing bilirubin oxidase | |
US5244798A (en) | Reagent for determining triglycerides comprising a thermostable lipoprotein lipase from streptomyces | |
JPS62239990A (en) | Novel lipase and production thereof | |
US5126246A (en) | Reagent for analysis of triglycerides and analysis using the same | |
JP7571418B2 (en) | Catalase | |
JP2017158441A (en) | Catalase | |
JP5470906B2 (en) | Catalase | |
JPS6362195B2 (en) | ||
JPS62240000A (en) | Method for measuring triglyceride | |
US4343903A (en) | Process for obtaining cholesterol esterase from micro-organisms | |
JPS5942888A (en) | Preparation of ester-bond hydrolase by microorganism | |
JP2724474B2 (en) | Decomposition method of fats and oils by enzymes | |
JPS5867183A (en) | Production of phospholipase d | |
SU1168103A3 (en) | Method of determining total cholesterol in blood serum | |
FR2517698A1 (en) | METHOD FOR DETERMINING ETHANOLAMINE | |
JPS6339579A (en) | Production of lipase aml | |
GB1571877A (en) | Microbial lipase and its preparation | |
JPH0866186A (en) | New lipase and its production |